Influence of ADAM metallopeptidase with thrombospondin type 1 motif 9 on the prognosis of patients with thyroid cancer and its mechanism of action

Objective To investigate the influence of ADAM metallopeptidase with thrombospondin type 1 motif 9 (ADAMTS9) on the prognosis of patients with thyroid cancer (THCA) and its potential mechanism of action. Methods TCGA database was used to obtain the data on the expression level of ADAMTS9 in THCA tis...

Full description

Saved in:
Bibliographic Details
Main Author: CAO Xiaodong, XIANG Cheng
Format: Article
Language:zho
Published: Editorial Office of Journal of Precision Medicine 2025-04-01
Series:精准医学杂志
Subjects:
Online Access:https://jpmed.qdu.edu.cn/fileup/2096-529X/PDF/1745982359547-2040579901.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849310715427422208
author CAO Xiaodong, XIANG Cheng
author_facet CAO Xiaodong, XIANG Cheng
author_sort CAO Xiaodong, XIANG Cheng
collection DOAJ
description Objective To investigate the influence of ADAM metallopeptidase with thrombospondin type 1 motif 9 (ADAMTS9) on the prognosis of patients with thyroid cancer (THCA) and its potential mechanism of action. Methods TCGA database was used to obtain the data on the expression level of ADAMTS9 in THCA tissue and the clinical data of patients, and HPA database was used to obtain the data on the protein expression level of ADAMTS9 in THCA tissue. The expression level of ADAMTS9 was compared between normal tissue and THCA tissue, as well as the degree and intensity of ADAMTS9 protein staining. A functional enrichment analysis was used to predict the biological processes involving ADAMTS9 in THCA. The Kaplan-Meier Plotter database was used to analyze the influence of the expression level of ADAMTS9 on the overall survival time of THCA patients, and gene set enrichment analyses were used to explore the potential signaling pathways associated with ADAMTS9 and important prognostic factors in THCA. Results Compared with normal tissue, THCA tissue showed a significantly higher expression level of ADAMTS9 (t=12.35,P<0.05) and significantly higher degree and intensity of ADAMTS9 protein staining (t=18.68,12.35,P<0.05). The functional enrichment analysis showed that ADAMTS9 mainly participated in the regulation of RNA slicing and gene expression. The patients with high ADAMTS9 expression had a significantly longer overall survival time than those with low expression (HR=0.22,95%CI=0.06-0.76,P<0.05). The pathway analysis showed that the expression level of ADAMTS9 was positively correlated with calcium signaling pathway score (NES=1.852,P<0.05) and was negatively correlated with glycosphingolipid biosynthesis pathway score and citrate cycle pathway score (NES=-1.581,-1.863,P<0.05). Age (HR=1.11,95%CI=1.05-1.67,P<0.05) was an independent prognostic factor for the overall survival time of patients, and significant enrichment of energy metabolism-related pathways was observed in elderly THCA patients, such as citrate cycle and fatty acid metabolism. Conclusion High mRNA and protein expression levels of ADAMTS9 are observed in THCA tissue, which is favorable to the prognosis of patients, possibly by inhibiting energy-related pathways. In addition, the effect of ADAMTS9 might offset the adverse effect of age on prognosis to a certain degree.
format Article
id doaj-art-257fa09d6d9b4a0faef3b8317bd78121
institution Kabale University
issn 2096-529X
language zho
publishDate 2025-04-01
publisher Editorial Office of Journal of Precision Medicine
record_format Article
series 精准医学杂志
spelling doaj-art-257fa09d6d9b4a0faef3b8317bd781212025-08-20T03:53:39ZzhoEditorial Office of Journal of Precision Medicine精准医学杂志2096-529X2025-04-0140215315710.13362/j.jpmed.202540042Influence of ADAM metallopeptidase with thrombospondin type 1 motif 9 on the prognosis of patients with thyroid cancer and its mechanism of actionCAO Xiaodong, XIANG Cheng0Department of Thyroid and Breast Surgery, Zhoukou Central Hospital, Zhoukou 466000, ChinaObjective To investigate the influence of ADAM metallopeptidase with thrombospondin type 1 motif 9 (ADAMTS9) on the prognosis of patients with thyroid cancer (THCA) and its potential mechanism of action. Methods TCGA database was used to obtain the data on the expression level of ADAMTS9 in THCA tissue and the clinical data of patients, and HPA database was used to obtain the data on the protein expression level of ADAMTS9 in THCA tissue. The expression level of ADAMTS9 was compared between normal tissue and THCA tissue, as well as the degree and intensity of ADAMTS9 protein staining. A functional enrichment analysis was used to predict the biological processes involving ADAMTS9 in THCA. The Kaplan-Meier Plotter database was used to analyze the influence of the expression level of ADAMTS9 on the overall survival time of THCA patients, and gene set enrichment analyses were used to explore the potential signaling pathways associated with ADAMTS9 and important prognostic factors in THCA. Results Compared with normal tissue, THCA tissue showed a significantly higher expression level of ADAMTS9 (t=12.35,P<0.05) and significantly higher degree and intensity of ADAMTS9 protein staining (t=18.68,12.35,P<0.05). The functional enrichment analysis showed that ADAMTS9 mainly participated in the regulation of RNA slicing and gene expression. The patients with high ADAMTS9 expression had a significantly longer overall survival time than those with low expression (HR=0.22,95%CI=0.06-0.76,P<0.05). The pathway analysis showed that the expression level of ADAMTS9 was positively correlated with calcium signaling pathway score (NES=1.852,P<0.05) and was negatively correlated with glycosphingolipid biosynthesis pathway score and citrate cycle pathway score (NES=-1.581,-1.863,P<0.05). Age (HR=1.11,95%CI=1.05-1.67,P<0.05) was an independent prognostic factor for the overall survival time of patients, and significant enrichment of energy metabolism-related pathways was observed in elderly THCA patients, such as citrate cycle and fatty acid metabolism. Conclusion High mRNA and protein expression levels of ADAMTS9 are observed in THCA tissue, which is favorable to the prognosis of patients, possibly by inhibiting energy-related pathways. In addition, the effect of ADAMTS9 might offset the adverse effect of age on prognosis to a certain degree.https://jpmed.qdu.edu.cn/fileup/2096-529X/PDF/1745982359547-2040579901.pdfthyroid neoplasms|adamts9 protein|gene expression|prognosis|energy metabolism|root cause analysis|computational biology|database, gentic
spellingShingle CAO Xiaodong, XIANG Cheng
Influence of ADAM metallopeptidase with thrombospondin type 1 motif 9 on the prognosis of patients with thyroid cancer and its mechanism of action
精准医学杂志
thyroid neoplasms|adamts9 protein|gene expression|prognosis|energy metabolism|root cause analysis|computational biology|database, gentic
title Influence of ADAM metallopeptidase with thrombospondin type 1 motif 9 on the prognosis of patients with thyroid cancer and its mechanism of action
title_full Influence of ADAM metallopeptidase with thrombospondin type 1 motif 9 on the prognosis of patients with thyroid cancer and its mechanism of action
title_fullStr Influence of ADAM metallopeptidase with thrombospondin type 1 motif 9 on the prognosis of patients with thyroid cancer and its mechanism of action
title_full_unstemmed Influence of ADAM metallopeptidase with thrombospondin type 1 motif 9 on the prognosis of patients with thyroid cancer and its mechanism of action
title_short Influence of ADAM metallopeptidase with thrombospondin type 1 motif 9 on the prognosis of patients with thyroid cancer and its mechanism of action
title_sort influence of adam metallopeptidase with thrombospondin type 1 motif 9 on the prognosis of patients with thyroid cancer and its mechanism of action
topic thyroid neoplasms|adamts9 protein|gene expression|prognosis|energy metabolism|root cause analysis|computational biology|database, gentic
url https://jpmed.qdu.edu.cn/fileup/2096-529X/PDF/1745982359547-2040579901.pdf
work_keys_str_mv AT caoxiaodongxiangcheng influenceofadammetallopeptidasewiththrombospondintype1motif9ontheprognosisofpatientswiththyroidcanceranditsmechanismofaction